Sentences with phrase «treating disorders of the brain»

Such research could one day help lead to next - generation brain - machine interfaces for controlling prosthetics, exoskeletons and robots, as well as «electroceuticals» to treat disorders of the brain and body.

This work could guide medical science by pointing researchers in the direction of other molecules that could be used to treat disorders of the brain, Slot said.

The cover story on novel ways of treating disorders of the brain (9 April, p 35) stated that «until recently...

Three researchers at the forefront of research on the microbiome - brain connection recently spoke with The Kavli Foundation about how microbes communicate with the brain and whether we can modify the gut microbiome to treat disorders of the brain and mind.

In - patient rehabilitation focuses on immediate medical and functional issues, with a range of health professionals involved, like physiotherapists, speech pathologists, neuropsychologists (psychologists who specialise in assessing, diagnosing and treating disorders of the brain) and occupational therapists.

Not exact matches

The gold - polyurethane material could someday be used in the form of implantable electrodes in the brain for treating movement disorders or in the heart to help regulate cardiac activity.

Eric Topol speaks with Edward Boyden about the promise of optogenetics, from treating common brain disorders to unlocking what it means to be human.

By accelerating discovery, we are leading the way to a better understanding of the developing brain and changing the way the world understands and treats children who struggle with mental health and learning disorders.

Our research is transforming the way we treat children with mental health and learning disorders, and leading the way to a better understanding of the developing brain.

Our research is unlocking the secrets of the developing brain and changing the way we diagnose and treat mental health and learning disorders.

Researchers use a brain - scanning technique to find differences in the neural connections of PTSD patients that could help researchers understand and treat the disorder

It is still a long road to approved therapies but a growing body of basic research is fueling a search for drugs that interact with cellular cleanup processes to provide one - size - fits - all approaches for treating a megaclass of brain disorders.

A new analysis of existing studies strongly supports the idea that there are increased levels of chemicals, called cytokines, in the body and brain that promote inflammation in individuals who are contemplating or have attempted suicide, even when compared to patients being treated for the same psychiatric disorders who are not suicidal.

A recent study published in Annals of Neurology reports that healthy human tissue grafted to the brains of patients with Huntington's disease in the hopes of treating the neurological disorder also developed signs of the illness, several years after the graft.

In the past decade, a handful of discoveries have unleashed a flood of research into ways neural stem cells can be used for treating degenerative brain disorders and for brain repair.

By doing so, members of Gould's laboratory pinpointed brain cells and regions important to anxiety regulation that may help scientists better understand and treat human anxiety disorders, she said.

Neuroscientists are now using optogenetics to map brain activity and test the effectiveness of an on / off switch in treating disorders.

«Our research should stimulate renewed clinical interest in developing glucocorticoid therapies to treat blast - induced traumatic brain injury (bTBI) and other disorders of the central nervous system,» Morrison says.

Until the last few decades, the frontal lobes of the brain were shrouded in mystery and erroneously thought of as nonessential for normal function — hence the frequent use of lobotomies in the early 20th century to treat psychiatric disorders.

Neurosurgeons at Barrow Neurological Institute in Phoenix are involved with testing the viability of deep brain stimulation (DBS) to treat Alzheimer's disease, a disorder that currently has few treatment options.

«In pursuit of pleasure, brain learns to hit the repeat button: New study in mice shows how the brain learns to reproduce patterns of brain activity that lead to reward; provides insights for treating addiction and obsessive - compulsive disorder.»

Recent research discoveries in the development of brain disorders could pave the way to new therapies for treating seizures, and even some children with autism, says a leading oncologist and researcher at the University of Alberta.

Eisenstat believes the findings have revealed a new pathway scientists could use to treat developmental brain disorders by getting to the root cause of problem.

«Researchers at multiple institutions are currently evaluating whether deep - brain stimulation of the amygdala is effective in treating severe cases of autism or post-traumatic stress disorder,» says Rutishauser.

This knowledge may help physicians treat other disorders of the brain

«The long - term goal of these efforts is to identify new ways to treat, cure, and even prevent brain disorders,» said Fish.

In animal models — and in one postmortem brain from a child who had been treated for a different disorder — Kurtzberg's team has found that donor cord blood can cross the blood - brain barrier that keeps the vast majority of molecules and cells out of the brain.

The findings open up new avenues of research into exactly how the brain controls eating, and suggest that drugs designed to activate or inhibit neurons in the DRN could be effective in treating obesity and preventing its related disorders, such as diabetes and hypertension.

The University of Bristol study, published today [17 Aug] in the Proceedings of National Academy of Sciences, could have important implications for treating symptoms of brain disorders.

Recent brain imaging research shows that people project themselves onto avatars, explaining the potential of digital doppelgängers for treating phobias and anxiety disorders and in helping people lose weight and make better financial choices.

The finding, published in Nature, could pave the way for these so - called intercalated cells in the amygdala, a brain region that processes fear, to become drug targets for treating phobias (such as fear of heights and closed spaces) as well as post-traumatic stress disorder in soldiers and others.

«A better understanding of the brain region and cell type - specific binding targets of Hnrnph1 will tell us more about the function of this gene and possibly identify new therapeutic strategies for minimizing risk and treating psychostimulant addiction — a disorder for which there is currently no FDA - approved drug,» explained corresponding author Camron Bryant, PhD, assistant professor of Pharmacology and Experimental Therapeutics & Psychiatry at BUSM.

Deep - brain stimulation has emerged as a technique to treat neurologic and neuropsychiatric disorders, including Parkinson's disease, dystonia, depression, and obsessive — compulsive disorder.2 - 5 The nature of the stimulation - induced modification of the neural circuit that results in improvement in patients with these disorders is not completely understood.

«This is the first instance I am aware of where an academic drug discovery group moved a molecule designed to hopefully treat a chronic brain disorder all the way from early discovery to human trials without there being, at some point along the way, a pharmaceutical partner,» said P. Jeffrey Conn, Ph.D., Lee E. Limbird Professor of Pharmacology in the Vanderbilt University School of Medicine and director of the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD).

Although researchers worldwide were publishing tens of thousands of neuroscience studies every year, neither our understanding of basic brain functions nor our ability to treat brain disorders seemed to be progressing much.

Furthermore, her research has also influenced the development of tests to assess, diagnose and treat people with brain disorders resulting from traumatic injury and degenerative diseases, as well as from psychiatric illness.

We hope that by understanding the genetic and environmental factors that predispose to mental illnesses, and understanding the mechanisms of disorders within the brain, that we can develop new strategies to better treat, manage, and ultimately to prevent them.

Demonstrated in Science in 2015, the system represents a noninvasive prototype that could help researchers unravel the neuronal underpinnings of brain disorders and someday help treat recalcitrant psychiatric and neurological diseases — without resorting to the bulky electrodes currently used for deep brain stimulation in the treatment of Parkinson's disease and some forms of depression.

Hundreds of scientists at Georgia's premiere universities, private colleges, and research institutes are at the forefront of some of the most promising efforts to understand the complexities of the brain, to alleviate the pain and suffering associated with brain disorders, and to reduce the cost of treating neurological disease.

«We're at a juncture in science that will change our understanding of the causes in brain disorders, and how to treat them,» Dr. Goldberg says.

Because many of the medications used to treat diseases ranging from anxiety disorders to epilepsy target the GABA system, it is important to have a clearer understanding of exactly how GABA acts in the brain.

Within the fields of microbiology and immunology, neurologic diseases, neuropharmacology, behavioral, cognitive and developmental neuroscience, and psychiatric disorders, the center's research programs are seeking ways to: develop vaccines for infectious and noninfectious diseases; understand the basic neurobiology and genetics of social behavior and develop new treatment strategies for improving social functioning in social disorders such as autism; interpret brain activity through imaging; increase understanding of progressive illnesses such as Alzheimer's and Parkinson's diseases; unlock the secrets of memory; treat drug addiction; determine how the interaction between genetics and society shape who we are; and advance knowledge about the evolutionary links between biology and behavior.

For example, deep brain stimulation (DBS)-- delivering an electrical current into the brain to modify nerve activity — has become a standard therapy for Parkinson's disease (PD), and it is now being adapted to treat a range of other conditions including depression and obsessive - compulsive disorder.

Parkinson's disease, a progressive brain disorder, is often tough to treat effectively because symptoms, such as tremors and walking difficulties, can vary dramatically over a period of days, or even hours.

In a 2013 TED talk, Dr. Andres Lozano, a neurosurgeon from the University of Toronto, talked about his research and work on deep brain stimulation, a technology used to treat Parkinson's disease, epilepsy and other neurological disorders.

The evidence: The brains of people with depression and bipolar disorder have been shown to have below - average levels of inositol, which prompted researchers to investigate whether inositol supplements could help treat depression.

Deep brain stimulation (DBS) is already used to treat some cases of Parkinson's disease and certain other brain - based disorders.

Brain Disorder Prevention by fueling the body and brain from ketones, instead of glucose, brain disorder such as Alzheimer's, Parkinson's disease, and epilepsy can be prevented and treBrain Disorder Prevention by fueling the body and brain from ketones, instead of glucose, brain disorder such as Alzheimer's, Parkinson's disease, and epilepsy can be prevented and Disorder Prevention by fueling the body and brain from ketones, instead of glucose, brain disorder such as Alzheimer's, Parkinson's disease, and epilepsy can be prevented and trebrain from ketones, instead of glucose, brain disorder such as Alzheimer's, Parkinson's disease, and epilepsy can be prevented and trebrain disorder such as Alzheimer's, Parkinson's disease, and epilepsy can be prevented and disorder such as Alzheimer's, Parkinson's disease, and epilepsy can be prevented and treated.

Dr. Mark Hyman's latest book, The UltraMind Solution (Scribner's, 2009) presents a highly convincing argument, backed by hundreds of peer - reviewed studies published within the last five years, for the validity of a functional medicine approach to treating brain disorders of all types.

If this is true, our attempt to treat brain disorders by controlling brain chemistry with psychiatric or psychotropic drugs (the second most prescribed class of drugs after cholesterol medication) is doomed to be ineffective.